[Long-term results of 2 therapeutic protocols in children with acute lymphoblastic leukemia of usual risk. Experience at the 20th of November National Medical Center]. [electronic resource]
Producer: 19980717Description: 145-51 p. digitalISSN:- 0016-3813
- Adolescent
- Age Factors
- Anti-Inflammatory Agents -- therapeutic use
- Antibiotics, Antineoplastic -- therapeutic use
- Antimetabolites, Antineoplastic -- therapeutic use
- Antineoplastic Agents, Alkylating -- therapeutic use
- Antineoplastic Agents, Hormonal -- therapeutic use
- Antineoplastic Agents, Phytogenic -- therapeutic use
- Antineoplastic Combined Chemotherapy Protocols -- therapeutic use
- Asparaginase -- therapeutic use
- Carmustine -- therapeutic use
- Child
- Child, Preschool
- Cyclophosphamide -- therapeutic use
- Cytarabine -- therapeutic use
- Data Interpretation, Statistical
- Disease-Free Survival
- Doxorubicin -- therapeutic use
- Female
- Humans
- Hydrocortisone -- therapeutic use
- Male
- Mercaptopurine -- therapeutic use
- Methotrexate -- therapeutic use
- Precursor Cell Lymphoblastic Leukemia-Lymphoma -- drug therapy
- Prednisone -- therapeutic use
- Risk Factors
- Time Factors
- Vincristine -- therapeutic use
No physical items for this record
Publication Type: Comparative Study; Journal Article
There are no comments on this title.
Log in to your account to post a comment.